350 related articles for article (PubMed ID: 22484034)
1. PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport.
Wan HT; Zhao YG; Wei X; Hui KY; Giesy JP; Wong CK
Biochim Biophys Acta; 2012 Jul; 1820(7):1092-101. PubMed ID: 22484034
[TBL] [Abstract][Full Text] [Related]
2. Chronic perfluorooctane sulfonate (PFOS) exposure induces hepatic steatosis in zebrafish.
Cheng J; Lv S; Nie S; Liu J; Tong S; Kang N; Xiao Y; Dong Q; Huang C; Yang D
Aquat Toxicol; 2016 Jul; 176():45-52. PubMed ID: 27108203
[TBL] [Abstract][Full Text] [Related]
3. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
4. Effect of prenatal PFOS exposure on liver cell function in neonatal mice.
Liang X; Xie G; Wu X; Su M; Yang B
Environ Sci Pollut Res Int; 2019 Jun; 26(18):18240-18246. PubMed ID: 31041707
[TBL] [Abstract][Full Text] [Related]
5. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.
Bijland S; Rensen PC; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; Havekes LM; Willems van Dijk K; Chang SC; Ehresman DJ; Butenhoff JL; Princen HM
Toxicol Sci; 2011 Sep; 123(1):290-303. PubMed ID: 21705711
[TBL] [Abstract][Full Text] [Related]
6. Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation.
Bagley BD; Chang SC; Ehresman DJ; Eveland A; Zitzow JD; Parker GA; Peters JM; Wallace KB; Butenhoff JL
Toxicol Sci; 2017 Dec; 160(2):284-298. PubMed ID: 28973659
[TBL] [Abstract][Full Text] [Related]
7. Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression.
Bjork JA; Lau C; Chang SC; Butenhoff JL; Wallace KB
Toxicology; 2008 Sep; 251(1-3):8-20. PubMed ID: 18692542
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis and CYP4A1 expression in Sprague-Dawley rats exposed to low doses of perfluorooctane sulfonate.
Kim HS; Jun Kwack S; Sik Han E; Seok Kang T; Hee Kim S; Young Han S
J Toxicol Sci; 2011 Apr; 36(2):201-10. PubMed ID: 21467747
[TBL] [Abstract][Full Text] [Related]
9. Fatty liver disease induced by perfluorooctane sulfonate: Novel insight from transcriptome analysis.
Fai Tse WK; Li JW; Kwan Tse AC; Chan TF; Hin Ho JC; Sun Wu RS; Chu Wong CK; Lai KP
Chemosphere; 2016 Sep; 159():166-177. PubMed ID: 27289203
[TBL] [Abstract][Full Text] [Related]
10. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.
Thibodeaux JR; Hanson RG; Rogers JM; Grey BE; Barbee BD; Richards JH; Butenhoff JL; Stevenson LA; Lau C
Toxicol Sci; 2003 Aug; 74(2):369-81. PubMed ID: 12773773
[TBL] [Abstract][Full Text] [Related]
11. Editor's Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in Mice.
Zhang L; Krishnan P; Ehresman DJ; Smith PB; Dutta M; Bagley BD; Chang SC; Butenhoff JL; Patterson AD; Peters JM
Toxicol Sci; 2016 Sep; 153(1):186-97. PubMed ID: 27413108
[TBL] [Abstract][Full Text] [Related]
12. Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system.
Yu WG; Liu W; Jin YH; Liu XH; Wang FQ; Liu L; Nakayama SF
Environ Sci Technol; 2009 Nov; 43(21):8416-22. PubMed ID: 19924978
[TBL] [Abstract][Full Text] [Related]
13. Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS).
Curran I; Hierlihy SL; Liston V; Pantazopoulos P; Nunnikhoven A; Tittlemier S; Barker M; Trick K; Bondy G
J Toxicol Environ Health A; 2008; 71(23):1526-41. PubMed ID: 18923995
[TBL] [Abstract][Full Text] [Related]
14. Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
Cwinn MA; Jones SP; Kennedy SW
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):165-71. PubMed ID: 18565798
[TBL] [Abstract][Full Text] [Related]
15. Effect of perfluorooctanesulfonic acid (PFOS) on the liver lipid metabolism of the developing chicken embryo.
Geng D; Musse AA; Wigh V; Carlsson C; Engwall M; Orešič M; Scherbak N; Hyötyläinen T
Ecotoxicol Environ Saf; 2019 Apr; 170():691-698. PubMed ID: 30580163
[TBL] [Abstract][Full Text] [Related]
16. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
Bjork JA; Butenhoff JL; Wallace KB
Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
[TBL] [Abstract][Full Text] [Related]
17. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism.
Yu WG; Liu W; Jin YH
Environ Toxicol Chem; 2009 May; 28(5):990-6. PubMed ID: 19045937
[TBL] [Abstract][Full Text] [Related]
18. Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.
Marques E; Pfohl M; Auclair A; Jamwal R; Barlock BJ; Sammoura FM; Goedken M; Akhlaghi F; Slitt AL
Toxicol Appl Pharmacol; 2020 Dec; 408():115250. PubMed ID: 32979393
[TBL] [Abstract][Full Text] [Related]
19. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
20. Global liver proteome analysis using iTRAQ labeling quantitative proteomic technology to reveal biomarkers in mice exposed to perfluorooctane sulfonate (PFOS).
Tan F; Jin Y; Liu W; Quan X; Chen J; Liang Z
Environ Sci Technol; 2012 Nov; 46(21):12170-7. PubMed ID: 23046066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
